Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

PILA PHARMA

1.21 SEK

-0.49 %

Less than 1K followers

PILA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Valuation
Income statement

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for PILA PHARMA

2019202020212022202320242025
Revenue0.30.71.91.50.81.1
growth-%161.5 %-22.3 %-46.6 %44.9 %
EBITDA-4.7-3.4-9.2-8.9-5.3-7.0-6.8
EBIT-4.7-3.4-9.3-8.9-6.4-8.1-7.9
Profit before taxes-8.7-7.0-17.2-26.8-9.9-11.2-16.9
Net income-8.7-7.0-17.2-26.8-9.9-11.2-16.8
EPS-0.47-0.38-0.93-1.38-0.05-0.39-0.62
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-1,357.8 %-1,285.1 %-471.8 %-364.4 %-901.3 %-603.5 %
EBIT-%-1,363.6 %-1,287.9 %-472.9 %-437.7 %-1,039.7 %-698.2 %
ROE-116.3 %-204.1 %-56.8 %-281.0 %-149.1 %-213.7 %-113.9 %
ROI-109.2 %-130.1 %-54.1 %-245.9 %-117.4 %-180.7 %-103.8 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.